GRK 2504: Preclinical evaluation of a combination of checkpoint blockade with dendritic cell vaccination against Merkel Cell Carcinoma and other virally induced cancers (B4) (GRK 2504 B4)

Third Party Funds Group - Sub project


Acronym: GRK 2504 B4

Start date : 01.10.2019

End date : 31.03.2024

Extension date: 30.09.2028

Website: https://www.virologie.uk-erlangen.de/grk2504/

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Single-Molecule RNA Sequencing Reveals IFN gamma-Induced Differential Expression of Immune Escape Genes in Merkel Cell Polyomavirus-Positive MCC Cell Lines (2021) Sauerer T, Lischer C, Weich A, Berking C, Vera J, Dörrie J Journal article Analysis of IFN gamma-mediated Transcriptome Changes in Merkel Cell Carcinoma Cell Lines via Nanopore Sequencing (2021) Sauerer T, Lischer C, Berking C, Vera-Gonzalez J, Dörrie J Conference contribution T-cell responses in merkel cell carcinoma: Implications for improved immune checkpoint blockade and other therapeutic options (2021) Gehrcken L, Sauerer T, Schaft N, Dörrie J Journal article, Review article Preclinical evaluation of a combination of checkpoint blockade and dendritic cell vaccination against Merkel cell carcinoma (2021) Sauerer T, Gerer K, Hoyer S, Erdmann M, Berking C, Voll R, Schuler-Thurner B, et al. Conference contribution